Roche ini­tial­ly did­n't want to buy Po­sei­da — and part­ner Astel­las did­n't sub­mit an of­fer, new fil­ings show

Well be­fore Roche said it would buy out its CAR-T part­ner Po­sei­da Ther­a­peu­tics for $1 bil­lion up­front, an­oth­er undis­closed phar­ma com­pa­ny had sent the cell …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER